| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.565 | 46.035 | 33.818 | 27.298 | 28.215 | 21.716 | 22.334 | 28.506 | 24.111 | 21.200 |
| Total Income - EUR | 26.565 | 46.035 | 33.818 | 27.300 | 28.218 | 21.718 | 22.337 | 28.521 | 24.126 | 21.242 |
| Total Expenses - EUR | 16.766 | 22.644 | 18.373 | 15.408 | 12.744 | 11.423 | 10.874 | 13.146 | 22.549 | 24.563 |
| Gross Profit/Loss - EUR | 9.798 | 23.391 | 15.446 | 11.892 | 15.474 | 10.295 | 11.463 | 15.375 | 1.577 | -3.322 |
| Net Profit/Loss - EUR | 9.002 | 22.010 | 14.431 | 11.073 | 14.627 | 9.643 | 10.793 | 14.678 | 1.340 | -3.959 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Adimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.616 | 8.554 | 6.648 | 7.122 | 5.099 | 4.425 | 3.783 | 3.311 | 18.120 | 19.418 |
| Current Assets | 11.885 | 22.504 | 16.833 | 13.263 | 17.807 | 13.660 | 14.873 | 20.435 | 9.623 | 11.268 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 60 | 0 | 0 | 0 |
| Receivables | 1.654 | 1.970 | 2.323 | 2.509 | 2.070 | 1.479 | 1.446 | 8.972 | 0 | 16 |
| Cash | 10.230 | 20.535 | 14.511 | 10.754 | 15.737 | 12.182 | 13.367 | 11.463 | 9.623 | 11.253 |
| Shareholders Funds | 21.083 | 30.348 | 22.629 | 19.120 | 22.519 | 17.385 | 18.363 | 22.271 | 17.048 | 19.041 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 418 | 710 | 852 | 1.264 | 388 | 701 | 294 | 1.475 | 10.696 | 11.646 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Adimed Srl